SEARCH

MEDIA PACK

NEWS

Current Edition

Aduhelm

Biogen’s Aduhelm records one patient death. Is the controversial Alzheimer’s drug to blame?

Doctors already have reservations about Biogen’s controversial Alzheimer’s disease drug, Aduhelm. Now a reported death will likely trigger more doubts around its use. One patient …

10 November 2021 Regional News Aduhelm Alzheimer

Continue Reading →

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.

SEARCH

MENU

Current Edition

Biogen’s Aduhelm records one patient death. Is the controversial Alzheimer’s drug to blame?

Journal for Clinical Studies